Inside the Team Principal & CEO’s playbook for futureproofing Mercedes-AMG $6 billion F1 empire for the next era.
The GLE 53 has been around since 2019, but the crossover it's based on was introduced a year earlier, and it's already been ...
Max Verstappen’s GT outfit – Verstappen Racing – has confirmed its headline-grabbing partnership with Mercedes-AMG Motorsport ...
The Mercedes-Benz G-Class Desert Expedition combines piloting G-Class variants through a gauntlet of dunes with glamping and ...
The facelifted Mercedes-AMG S 63 E Performance won't look like this at all, which is sad, as we think this is one stunning ...
A prototype CLE with a V8 has finally been spotted on video, yet the engine barely makes a sound. We're excited… and a little ...
Nikita Chuicko, the virtual artist better known as "kelsonik" on social media, thinks that now is the right CGI time to work ...
A mid-stage trial of oral ketamine tablets has shown promising results in treatment-resistant depression (TRD), setting up a phase 3 programme and a possible challenge to Johnson & Johnson’s Spravato.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback